NCT05187819View on ClinicalTrials.gov

Blood-based Biomarkers for Diagnosis of Alzheimer's

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Dementia Alzheimers
Interventions
DIAGNOSTIC_TEST

predictive value of a blood test

Evaluation of the clinical value of a new blood based test for diagnosis of Alzheimer's disease in a general practice population.

Trial Locations (1)

4068

RECRUITING

Stavanger University Hospital, Stavanger

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Helse Stavanger HF

OTHER_GOV